COMPASS Pathways launches new podcast “Everyone has a story: talking about...

Comparing Psilocybin Mushroom Bruising with Trichoderma Infection

PT250 – Matt Ball – New Frameworks For Schizophrenia, Dissociation, and...

Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and...

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in...

Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board

Awakn Life Sciences Files Patent Applications In U.S. For AWKN001 And...

MindMed Included in FTSE Russell 3000® Index

Psychedelic Bulletin: Ex-FDA Psychiatry Director Joins Cybin as Advisor; Texas Approves...

Psychedelic Treatment for Eating Disorder Recovery

Load more